华昊中天医药-B发布中期业绩 净亏损5404.1万元 同比收窄23.41%

Core Insights - The company reported a significant decline in revenue for the six months ending June 30, 2025, with total revenue of 14.787 million RMB, representing a year-on-year decrease of 55.36% [1] - The net loss for the period was 54.041 million RMB, which is a reduction of 23.41% compared to the previous year [1] - The basic loss per share was reported at 0.15 RMB [1]